Search Results 251-260 of 16738 for alt

  1. A Study Of Treatment For Medulloblastoma Using Sodium Thiosulfate To Reduce Hearing Loss - Mayo Clinic

    ... (ALT) has been set to the value of 45 U/L. Central nervous system function defined as: Patients with seizure disorder may be enrolled if on anticonvulsants ...

  2. Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients with ALS - Mayo Clinic

    Serum AST or ALT value >3.0 times the upper normal limit. Serum creatinine value >2.0 times the upper normal limit. Positive test for Hepatitis B, Hepatitis ...

  3. Molecular Regulation of Muscle Glucose Metabolism - Mayo Clinic

    ALT (SGPT) < 2 times upper limit of normal; Alkaline phosphatase < 2 times upper limit of normal; Triglycerides < 150 mg/dl. PT 11.7 -14.3 (During Liposyn ...

  4. A Study Using A New Drug, Nivolumab, In Combination With Chemotherapy Drugs To Treat A Type Of Cancer Called Nasopharyngeal Carcinoma (NPC) - Mayo Clinic

    ... (ALT) has been set to the value of 45 U/L * Shortening fraction of ≥ 27% by echocardiogram, or * Ejection fraction of ≥ 50% by radionuclide angiogram * No ...

  5. Safety of MT-401-OTS in Patients with Relapsed AML or MDS - Mayo Clinic

    AST and ALT < 3 × ULN; for participants with leukemic infiltration of the liver (documented by biopsy or imaging), AST and ALT < 5 × ULN is permitted. Total ...

  6. A Study of TRK-950 in Patients With Advanced Solid Tumors - Mayo Clinic

    AST (SGOT), ALT (SGPT) and Alkaline Phosphatase ≤ 2.5 times upper limit of normal (if liver metastases are present, then ≤ 5 x ULN is allowed). Acceptable ...

  7. Study to Assess the Safety, Tolerability, Efficacy and PK of APL-2 in Patients With wAIHA or CAD - Mayo Clinic

    Abnormal liver function as indicated by elevated AST or ALT. Any elevation of AST or ALT level >2x upper limit of normal (ULN) will require Sponsor review and ...

  8. Effect Of TAK-954 On Gastrointestinal And Colonic Transit In Diabetic Or Idiopathic Gastroparesis Participants - Mayo Clinic

    Participation eligibility · AST or ALT >2 times the upper limit of normal (ULN). · Bilirubin >1.5 times the ULN unless due to Gilbert's syndrome. · International ...

  9. Momelotinib Versus Ruxolitinib in Subjects With Myelofibrosis - Mayo Clinic

    Platelet Count ≥ 50 x 10^9/L (≥ 100 x 10^9/L if aspartate aminotransferase [AST] or alanine aminotransferase [ALT] is ≥ 2 x the upper limit of the normal ...

  10. MEDI5395 Advanced Solid Tumors - Clinical Trials

    Hepatic ALT ≤ 2.5 × ULN;; AST ≤ 2.5 × ULN;; TBL ≤ 1.5 × ULN [≤ 3 × ULN if the subject has documented Gilbert's syndrome];; Albumin ≥ 3 g/dL;; Renal ...